26 /100
MEDIUM RISK
Score updated May 30, 2026

MLYS — Mineralys Therapeutics, Inc. Dilution Risk Tracker

Track MLYS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MLYS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for MLYS.
🔔 Track MLYS — Get forecast alerts →

💹 Market Data

Market Cap$2.60B
Shares Outstanding82.50M
Float60.37M
Cash$646.06M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 26.2% shares (2025Q4 vs prior)
227 institutional holders · 101.67M shares
#1 Catalys Pacific, LLC 7.90M shares
#2 RA CAPITAL MANAGEMENT, L.P. 7.32M shares
#3 SAMSARA BIOCAPITAL, LLC 5.87M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest9.02M
Days to Cover8.2
% of Float14.9%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Feb 07, 2024
xbrl XBRL CONVERTIBLE Dec 31, 2023
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Mar 31, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track MLYS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MLYS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for MLYS
📊 MLYS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MLYS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.